Therapeutic monoclonal antibodies for diabetic kidney disease: a narrative review from basic mechanisms to clinical evidence.

Front Endocrinol (Lausanne) · 2026 · PMC13391339 · PMID 42494867

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Exploratory analyses showed a nonsignificant trend toward reduced kidney failure (HR 0.80, 95% CI 0.61–1.05), but a significant reduction in the composite of death or kidney failure (HR 0.81, 95% CI 0.68–0.96) ( 29 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.